Monsanto Co. chairman Hugh Grant said the firm's U.S. and ex-U.S. corn seeds and traits business, international traits business and R&D pipeline will contribute to the company's growth through the end of the decade.
Published in Brief:
|Vice President of Regulatory Affairs||
|Sr Coordinator Clinical Research (US/TA/00/0073/SL) - 1400000AQX||
|Santa Clara, CA|
|Senior Director, Biostatistics||